REGULATORY INTELLIGENCE·Recall
Fresenius Kabi's Class I Dexmedetomidine HCl Recall Signals Critical Cross-Contamination Risks
Fresenius Kabi USA, LLC initiated a Class I recall of 25,100 bottles of Dexmedetomidine HCl due to trace lidocaine cross-contamination. This event, terminated in September 2022, underscores severe quality control vulnerabilities in sterile injectable manufacturing. Procurement and regulatory teams must scrutinize supplier quality systems to mitigate supply chain disruption and patient safety risks from such critical drug product issues.
90-Day Activity